Related Experiment Video
Updated: Jul 2, 2026
17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
10.7K
Nanotheranostics: emerging nanomachines as pharmacotherapeutics.
Bina Gidwani1, Varsha Sahu2, Kamal Shah3
1Department of Pharmaceutical Analysis and Quality Assurance, Columbia Institute of Pharmacy, Raipur, Chattisgarh India.
3 Biotech
|November 24, 2025
Summary
Nanotheranostics, combining diagnosis and therapy at the nanoscale, shows great promise. Overcoming manufacturing and regulatory hurdles is key for clinical translation of these advanced nanoparticle systems.
Area of Science:
- Nanomedicine and nanobiotechnology.
- Interdisciplinary field of nanoscience and nanotechnology.
Background:
- Nanoparticles offer unique properties due to their small size and large surface area.
- Nanotheranostics integrate diagnostic and therapeutic functions at the nanoscale for precision medicine.
Purpose of the Study:
- To review current advancements in nanotheranostic approaches.
- To highlight strategies like targeted delivery, stimuli-responsive systems, and versatile nanoparticles.
- To discuss barriers and progress toward clinical translation.
Main Methods:
- Systematic review of nanotheranostic research.
- Emphasis on prominent strategies for synchronized imaging and treatment.
- Analysis of preclinical results versus clinical limitations.
Main Results:
- Nanotheranostics utilize targeted delivery, stimuli-responsive systems, and versatile nanoparticles.
- Significant preclinical success contrasts with limited clinical translation.
- Barriers include manufacturing complexity, pharmacokinetics, and regulatory standardization.
Conclusions:
- Regulatory agencies are developing frameworks for nanomedicine safety and efficacy.
- Robust clinical validation and interdisciplinary collaboration are essential.
- Bridging the gap between lab innovation and patient application is crucial for nanotheranostics.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.